Plasmacytoma — Trials

Plasmacytoma — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04166565	Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease(EMN19)	active not recruiting	Phase 2	41	Stichting European Myeloma NetworkNETWORK	3	Apr 20, 2026	clinicaltrials
NCT04174196	A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma	active not recruiting	Phase 2	21	Memorial Sloan Kettering Cancer CenterOTHER